Last reviewed · How we verify

NCT03909672: cupping

Cupping Therapy in Nonspecific Chronic Low Back Pain

Completed NA Last updated 21 February 2020
What this trial tests

NA trial testing Cupping Therapy in Low Back Pain in 90 participants. Completed in 20 February 2020.

Timeline
10 June 2019
Primary endpoint
10 December 2019
20 February 2020

Quick facts

Lead sponsorUniversidade Federal do Rio Grande do Norte
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment90
Start date10 June 2019
Primary completion10 December 2019
Estimated completion20 February 2020
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Universidade Federal do Rio Grande do Norte — full company profile →

Who can join

Adults 18 to 59, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: Low back pain is a very prevalent condition in the population and windsurf therapy has been presented as a non-pharmacological treatment currently used in this population. However, there is a lack of studies that evaluate such effects, besides a standardization of application of the technique in this condition. This protocol describes a placebo-controlled, randomized, double-blind study that aims to assess the effectiveness of windsurf therapy in improving pain and other symptoms of individuals with chronic non-specific back pain. Methods: Ninety individuals with chronic nonspecific and localized chronic low back pain from 18 to 59 years, will be recruited according to the inclusion criteria. Afterwards they will be randomized to one of the 2 groups: intervention group (GI) where it will be submitted applied to the windspiration with 2 suctions; and placebo group (GP) with simulated application. Both applications will occur in parallel to the vertebrae from L1 to L5 bilaterally. The application will be performed once a week for eight weeks. The volunteers will be evaluated before treatment (T0), immediately after the first intervention (T1), 4 weeks after treatment (T4) and 8 weeks after treatment (T8). The primary endpoint will be pain, and the secondary ones will be kinesiophobia, physical function, lumbar range of motion, sleep quality, patient expectation, quality of life, and psychological factors. Discussion: This is the first protocol that proposes to evaluate the effect of windsotherapy on lumbar ROM, sleep quality, kinesiophobia and psychological problems. Few studies have been done on windsurfing individuals with low back pain, requiring further studies with good methodological quality. Because there is no consensus on the use of windsurf therapy in individuals with nonspecific chronic low back pain, our protocol will be the basis for the use of the technique by health professionals and for new studies to be performed.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Dry cupping therapy is not superior to sham cupping to improve clinical outcomes in people with non-specific chronic low back pain: a randomised trial.
    Almeida Silva HJ, Barbosa GM, Scattone Silva R, Saragiotto BT, et al · · 2021 · cited 17× · PMID 33757719 · DOI 10.1016/j.jphys.2021.02.013
  2. Dry cupping in the treatment of individuals with non-specific chronic low back pain: a protocol for a placebo-controlled, randomised, double-blind study.
    Silva HJA, Saragiotto BT, Silva RS, Lins CAA, et al · · 2019 · cited 15× · PMID 31871257 · DOI 10.1136/bmjopen-2019-032416

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Universidade Federal do Rio Grande do Norte trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03909672.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing